|
|
|
|
|
| October 14,
2010 | ISSUE NUMBER 170 VOL 8 |
Mergers
Pfizer to Acquire King Pharmaceuticals
The $3.6 billion deal gives Pfizer access to King’s therapeutics for pain market.
Growth
Pipelines Begin to Show Promise
A predicted 5 percent to 7 percent growth of the global pharma industry for 2011 surpasses the pace of increase from 2010.
Asset Management
Facilities Buyers in Short Supply
Jim Miller explains why global pharmaceutical companies could have a problem getting rid of redundant facilities.
New & Noteworthy
The Testing of the Tests
The diagnostic testing business is taking off, moving into genetic testing and more direct-to-consumer marketing, and raising red flags all over, says Jill Wechsler.
|
|
 // Jeff Wendel, Chief Operating Officer of Chesapeake Research Review (Chesapeake, Va.), has been appointed to the Association for the Accreditation of Human Research Protections Programs’ (AAHRPP) Board of Directors. //IntegriChain (Princeton, NJ) has hired Gregory Cornellier as its new Vice President of Development.// Glasgow, UK-based CRO ClinTec expanded its Philadelphia operations with the appointment of Executive Vice President Dr. Dianne Kikta. //James Welch has joined Redwood City, Calif.-based AcelRx as Chief Financial Officer HC&B Healthcare Communications (Austin, Texas) hired Christina Folger as Project Manager. // |
|
|
|
Oct 20–21 Innovative Contracting for Bio/Pharmaceuticals
London, UK
Nov 4 SharePoint User Workshop for the Life Sciences Industry
Princeton, NJ
Dec 8–9 CMAC 2010 - Commercialization and Market Access Congress
Orlando, FL |
|
|
7th Annual Defining Effective and Appropriate Interactions with Thought Leaders and Key Opinion Leaders (KOLs)
November 3 - 4, 2010 Princeton, NJ
Maximize KOL Collaboration across the Organization while Ensuring Compliance
Save $200 - mention promotional code ZSM643
 www.cbinet.com/KOL
| 800-817-8601
Discount offer cannot be combined with other discounts or applied to a current registration.
Not valid on workshop only or academic registrations. |
|
|
|
|
|
 |
|
 |
|
 |
| What is likely to be the most promising therapy area over the next 10 years? |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
